生物制造行业

Search documents
 国家发改委:着力指导推动人工智能、生物制造等新增长引擎!
 合成生物学与绿色生物制造· 2025-09-23 03:52
 Core Viewpoint - The bio-manufacturing industry is entering a new phase of accelerated development characterized by clear policies, specific support, and close integration with the real economy [7].   Policy Developments - The National Development and Reform Commission (NDRC) has emphasized the importance of bio-manufacturing as a key part of light industry upgrades, particularly in sectors such as plastic products, textiles, food and beverages, household chemicals, cosmetics, leather, and paper industries [6]. - The recent announcement from the Ministry of Industry and Information Technology highlights support for bio-based, biodegradable materials, and bio-manufacturing industries as part of the "Light Industry Growth Stabilization Work Plan (2025-2026)" [6].   Industry Transformation - Bio-technology is driving a systematic transformation of the light industry from a "resource-consuming" and "cost-competitive" model to a new paradigm focused on green, intelligent, and high-end development through raw material revolution, process innovation, functional upgrades, and supply chain security [6].   Economic Integration - The government is guiding localities to develop new growth engines such as artificial intelligence and bio-manufacturing, focusing on the integration of these technologies into traditional industries to enhance productivity and innovation [4].
 华恒生物:9月4日召开董事会会议
 Mei Ri Jing Ji Xin Wen· 2025-09-04 13:48
每经头条(nbdtoutiao)——烤肉店里洗头、西湖边开面包店、进军高端酒店……海底捞"不务正业"背 后:子品牌存活率不足50% (记者 张喜威) 每经AI快讯,华恒生物(SH 688639,收盘价:35.88元)9月4日晚间发布公告称,公司第四届第二十三 次董事会会议于2025年9月4日在公司会议室以现场结合通讯方式召开。会议审议了《关于确认公司董事 角色的议案》等文件。 2024年1至12月份,华恒生物的营业收入构成为:生物制造行业占比82.87%,其他业务占比17.13%。 截至发稿,华恒生物市值为90亿元。 ...

